Vaccine and Infectious Disease Division

Scientist with petri dish

Featured News from VIDD

Glenda Gray

Glenda Gray

Glenda Gray appointed new president of South African Medical Research Council

HIV expert Dr. Glenda Gray, VIDD member and co-principal investigator of the HIV Vaccine Trials Network, has been named president of the South African Medical Research Council, the premier medical research organization and funder of medical research in South Africa. 

More Featured News from VIDD »

 

Upcoming VIDD Events

 

Faculty Meeting
Faculty Meeting
Tuesday, September 23

Faculty Meeting
Faculty Meeting
Tuesday, December 16

VIDD Faculty Stories

 

Going back in time to predict the future of influenza with Trevor Bedford
Dr. Trevor Bedford, assistant member of VIDD and PHSD, uses epidemiology, genetic analyses and statistical modeling to make predictions about which influenza strains are likely to be successful pathogens.

More VIDD Faculty Stories »

VIDD Publication Spotlight

 

New anti-HSV-2 drug reduces genital viral shedding
Thirty years ago, Seattle scientists were instrumental in demonstrating that the drug acyclovir was efficacious for curbing HSV-2 symptoms and promoting genital ulcer healing. However, it does not completely eliminate HSV reactivation and shedding.Thus, the hunt for alternative drugs continues.

More VIDD News »

Find VIDD Faculty

 

International Spotlight

 

Uganda
Uganda offers a unique setting to study the impact of infections on the development and clinical course of several cancers.

More International Programs »

VIDD Announcements

 

After 13 years in a variety of executive roles at Fred Hutch, Banks Warden is going to take on one more.

Banks will step back from the HVTN COO position to assume a part-time role in the Director’s Office, working on special projects for Larry Corey and Myra Tanita.


Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.